Literature DB >> 12101017

Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis.

M Luisa Corvo1, João C S Jorge, Ron van't Hof, M Eugénia M Cruz, Daan J A Crommelin, Gert Storm.   

Abstract

The aim of this study was to investigate whether long-circulating liposomes can improve the anti-inflammatory activity of superoxide dismutase (SOD). Small-sized poly(ethyleneglycol) (PEG)-liposomes containing SOD were prepared via different preparation protocols and characterized in terms of encapsulation efficiency (EE), size, enzymatic activity and protein structure, to establish conditions where high EE can be combined with preservation of enzyme activity and structure. It was observed that structural information from circular dichroism analyses does not correlate with data on enzyme activity. SOD-containing PEG-liposomes prepared by the dehydration-rehydration method appeared to represent the most attractive formulation for in vivo evaluation. The therapeutic potential of selected SOD-containing PEG-liposomes was established and compared with SOD entrapped in stearylamine (SA)-liposomes and 'free' SOD upon intravenous (i.v.) injection in an arthritic rat model. Both small PEG-liposomes and SA-liposomes showed a superior therapeutic activity compared to 'free' SOD, with PEG-liposomes inducing stronger anti-inflammatory effects than SA-liposomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101017     DOI: 10.1016/s0005-2736(02)00457-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Nanomedicines for chronic non-infectious arthritis: the clinician's perspective.

Authors:  Israel Rubinstein; Guy L Weinberg
Journal:  Nanomedicine       Date:  2012-05-26       Impact factor: 5.307

2.  Fermentative production of superoxide dismutase with Kluyveromyces marxianus.

Authors:  Clementina Dellomonaco; Alberto Amaretti; Simona Zanoni; Anna Pompei; Diego Matteuzzi; Maddalena Rossi
Journal:  J Ind Microbiol Biotechnol       Date:  2006-08-15       Impact factor: 3.346

Review 3.  Nanocarriers for vascular delivery of anti-inflammatory agents.

Authors:  Melissa D Howard; Elizabeth D Hood; Blaine Zern; Vladimir V Shuvaev; Tilo Grosser; Vladimir R Muzykantov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 4.  Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.

Authors:  Ibra S Fancher; Israel Rubinstein; Irena Levitan
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 5.  Enzymes as Immunotherapeutics.

Authors:  Shaheen A Farhadi; Evelyn Bracho-Sanchez; Sabrina L Freeman; Benjamin G Keselowsky; Gregory A Hudalla
Journal:  Bioconjug Chem       Date:  2018-01-31       Impact factor: 4.774

Review 6.  Nanocarriers for vascular delivery of antioxidants.

Authors:  Elizabeth Hood; Eric Simone; Paritosh Wattamwar; Thomas Dziubla; Vladimir Muzykantov
Journal:  Nanomedicine (Lond)       Date:  2011-09       Impact factor: 5.307

Review 7.  Targeting therapeutics to endothelium: are we there yet?

Authors:  Raisa Yu Kiseleva; Patrick M Glassman; Colin F Greineder; Elizabeth D Hood; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

8.  Evaluation of complete Freund's adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology.

Authors:  U Snekhalatha; M Anburajan; B Venkatraman; M Menaka
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

9.  Superoxide dismutase enzymosomes: carrier capacity optimization, in vivo behaviour and therapeutic activity.

Authors:  M Luísa Corvo; H Susana Marinho; Paulo Marcelino; Rui M Lopes; Carlos A Vale; Claúdia R Marques; Luísa C D Martins; Peter Laverman; Gert Storm; M Bárbara A F Martins
Journal:  Pharm Res       Date:  2014-07-19       Impact factor: 4.200

10.  Effect of an oral supplementation with a proprietary melon juice concentrate (Extramel) on stress and fatigue in healthy people: a pilot, double-blind, placebo-controlled clinical trial.

Authors:  Marie-Anne Milesi; Dominique Lacan; Hervé Brosse; Didier Desor; Claire Notin
Journal:  Nutr J       Date:  2009-09-15       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.